Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127598851 | 12759885 | 1 | I | 20160831 | 20160919 | 20160919 | EXP | TR-UNICHEM LABORATORIES LIMITED-UCM201609-000205 | UNICHEM | UZ Y,HARIRI A,UNUBOL H,BILICI M. STUPOR DUE TO POSSIBLE INTERACTION BETWEEN LORAZEPAM AND VALPROIC ACID: REPORT OF TWO CASES. TURKISH JOURNAL OF PSYCHIATRY 2012;23(4):1-2. | 25.00 | YR | F | Y | 0.00000 | 20160919 | MD | TR | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127598851 | 12759885 | 1 | PS | DIVALPROEX SODIUM. | DIVALPROEX SODIUM | 1 | Y | 79163 | 1000 | MG | |||||||||
| 127598851 | 12759885 | 2 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | Y | 0 | 2.5 | MG | ||||||||
| 127598851 | 12759885 | 3 | C | HALOPERIDOL. | HALOPERIDOL | 1 | 0 | 10 | MG | ||||||||||
| 127598851 | 12759885 | 4 | C | Biperiden | BIPERIDEN | 1 | 0 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127598851 | 12759885 | 2 | Anxiolytic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127598851 | 12759885 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127598851 | 12759885 | Drug interaction | |
| 127598851 | 12759885 | Stupor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |